Axolabs GmbH
Records under this name other than the patents Axolabs GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,920,227 | Compositions and Methods of Treating Amyotrophic Lateral Sclerosis (ALS) Formerly held In force · High confidence | In force | High confidence | |
| US 12,123,002 | Compositions and Methods of Treating Amyotrophic Lateral Sclerosis (ALS) Formerly held In force · High confidence | In force | High confidence | |
| US 11,542,506 | Compositions and Methods of Treating Amyotrophic Lateral Sclerosis (ALS) Formerly held In force · High confidence | In force | High confidence | |
| US 10,597,660 | Compositions and Methods of Treating Amyotrophic Lateral Sclerosis (ALS) Formerly held In force · High confidence | In force | High confidence | |
| US 10,912,790 | C/EBP alpha saRNA compositions and methods of use Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,352,629 | Defined Multi-Conjugate Oligonucleotides Formerly held In force · High confidence | In force | High confidence | |
| US 11,951,121 | Compositions and Methods for Treating Huntington's Disease Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,078,484 | Multimeric Oligonucleotides Having Decreased Kidney Clearance Formerly held In force · High confidence | In force | High confidence | |
| US 12,378,551 | Multimeric Oligonucleotides Having Decreased Kidney Clearance Formerly held In force · High confidence | In force | High confidence | |
| US 11,965,163 | HNF4a saRNA compositions and methods of use Formerly held In force · From the USPTO record | In force | From the USPTO record |